Bora Pharma guarantees additional NTD 630,300 for subsidiary Upsher-Smith Laboratories
- Bora Pharmaceuticals increased financial guarantees for 100%-indirect subsidiary Upsher-Smith Laboratories by TWD 630.3 million on May 13, 2026, lifting outstanding guarantees to TWD 787.88 million.
- Total endorsements and guarantees outstanding stood at TWD 11.39 billion, equal to 78.2% of net worth.
- Upsher-Smith reported capital of TWD 31.28 billion, cumulative loss of TWD 24.3 billion.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bora Pharmaceuticals Co. Ltd. published the original content used to generate this news brief on May 13, 2026, and is solely responsible for the information contained therein.
